Status:

RECRUITING

Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)

Lead Sponsor:

Indiana University

Conditions:

Pancreatitis

Pancreatectomy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measur...

Detailed Description

Patients will be identified utilizing preoperative scheduling and clinic visits. Patients undergoing any pancreatectomy (such as: pancreatoduodenectomy, distal pancreatectomy, duodenal preserving panc...

Eligibility Criteria

Inclusion

  • Older than 18 years of age
  • Undergoing elective pancreatectomy for any indication

Exclusion

  • Younger than 18 years of age
  • Pregnant women
  • Prisoner

Key Trial Info

Start Date :

August 5 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06903676

Start Date

August 5 2025

End Date

April 1 2026

Last Update

September 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Indiana University Health University Hospital

Indianapolis, Indiana, United States, 46202